04:43 AM EDT, 10/31/2025 (MT Newswires) -- Travere Therapeutics ( TVTX ) reported Q3 non-GAAP earnings late Thursday of $0.59 per share, swinging from a loss of $0.46 a year earlier.

Analysts polled by FactSet expected a loss of $0.05.

Total revenue for the quarter ended Sept. 30 was $164.9 million, up from $62.9 million a year earlier.

Analysts' estimates weren't readily available for comparison.